<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=377593866636424&amp;ev=PageView&amp;noscript=1">


Technology Strategy

Decentralized clinical trials: A growth lever for scaling life sciences organizations

During the COVID-19 pandemic, we’ve seen a marked boom in alternative clinical trial arrangements that can accommodate the myriad of new restrictions and considerations, such as decentralized clinical trials. But what, exactly, are decentralized clinical trials? Decentralized clinical trials are described by the Clinical Trials Transformation Initiative as “trials consisting of any combination of certain core features, including no physical trial sites used in the trial, all visits performed via telemedicine or mobile/local HCPs, and/or data captured remotely through use of mobile technologies.”